1. Home
  2. RCAT vs MNKD Comparison

RCAT vs MNKD Comparison

Compare RCAT & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$9.17

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$4.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
MNKD
Founded
2002
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
RCAT
MNKD
Price
$9.17
$4.11
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$20.00
$8.69
AVG Volume (30 Days)
7.3M
4.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
$348,966,000.00
Revenue This Year
$271.60
$35.81
Revenue Next Year
$41.21
$11.89
P/E Ratio
N/A
N/A
Revenue Growth
79.95
22.23
52 Week Low
$5.77
$2.23
52 Week High
$18.78
$6.51

Technical Indicators

Market Signals
Indicator
RCAT
MNKD
Relative Strength Index (RSI) 50.94 45.88
Support Level $8.61 $3.78
Resistance Level $8.85 $3.94
Average True Range (ATR) 0.59 0.22
MACD 0.24 -0.02
Stochastic Oscillator 84.14 20.18

Price Performance

Historical Comparison
RCAT
MNKD

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: